// company-profile

Black Diamond Therapeutics, Inc.

BDTX
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Filings77Insiders26
// api This Black Diamond Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares (net $28K). Buying was led by Behbahani Ali.

// 90-day insight

Over the last 90 days, Black Diamond Therapeutics, Inc. insiders bought $28K across 2 transactions with no open-market sales.

  • Most active insider: Behbahani Ali with 1 transaction totaling $15K.
  • Largest single purchase: $15K by Behbahani Ali on Jun 19, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Black Diamond Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$50.5M
QoQ change
-15.8%
Reporting period
2026-03-31
#1
NEA Management Company, LLC
CIK 1512848
$9.5M
4.4M shares
#2
RENAISSANCE TECHNOLOGIES LLC
CIK 1037389
$3.5M
1.6M shares
#3
DIMENSIONAL FUND ADVISORS LP
CIK 354204
$2.7M
1.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 19, 2026Behbahani AliBDTX
Award
8,961$1.66$15K
Jun 19, 2026Raman PrakashBDTX
Award
7,907$1.66$13K
Mar 20, 2026Behbahani AliBDTX
Award
6,919$2.15$15K
Mar 20, 2026Raman PrakashBDTX
Award
6,105$2.15$13K
Jan 21, 2026Jones ErikaBDTX
Award
200,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.